default author photo

Logan K. Baker

Government of the United States of America - Center for Drug Evaluation and Research

SCHOLARLY PAPERS

2

DOWNLOADS

136

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Rvsv-Ebov-Gp Challenge Models Acute and Chronic Eye Infections with Ebola and Can Be Used to Test Therapeutics that Target the Ebola Glycoprotein

Number of pages: 51 Posted: 28 Nov 2023
Ha-Na Lee, Biying Xu, Aaron P. Lewkowicz, Kaliroi Engel, Logan K. Baker, Ian L. McWilliams, Derek D.C. Ireland, Jennifer L. Kielczewski, Jinbo Li, Robert N. Fariss, Mercedes M. Campos, Alina Baum, Christos A. Kyratsous, Kristen E. Pascal, Chi-Chao Chan, Rachael R. Caspi, Mohanraj Manangeeswaran and Daniela Verthelyi
Government of the United States of America - Center for Drug Evaluation and Research, Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - Center for Drug Evaluation and Research, Government of the United States of America - Center for Drug Evaluation and Research, Government of the United States of America - Center for Drug Evaluation and Research, Government of the United States of America - Center for Drug Evaluation and Research, Government of the United States of America - Center for Drug Evaluation and Research, Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), ​Regeneron Pharmaceutical, Inc., ​Regeneron Pharmaceutical, Inc., ​Regeneron Pharmaceutical, Inc., Government of the United States of America - National Institutes of Health (NIH), Government of the United States of America - National Institutes of Health (NIH), affiliation not provided to SSRN and Government of the United States of America - Center for Drug Evaluation and Research
Downloads 102 (679,608)

Abstract:

Loading...

Ebola virus (EBOV), EBOV glycoprotein (EBOV-GP), EBOV-GP pseudotyped vesicular stomatitis virus (VSV-EBOV), BSL-2 model, anti-EBOV-GP antibodies, retinitis, ocular sequelae

2.

BSL2-Compliant Lethal Mouse Model of SARS-CoV-2 and Variants of Concern to Evaluate Therapeutics Targeting the Spike Protein

Number of pages: 36 Posted: 22 Feb 2022
Mohanraj Manangeeswaran, Derek D.C. Ireland, Seth Thacker, Ha-Na Lee, Logan K. Baker, Aaron Lewkowicz, Paul W. Rothlauf, Marjorie Cornejo Pontelli, Louis-Marie Bloyet, Michael A. Eckhaus, Mirian Mendoza, Sean P. J. Whelan and Daniela Verthelyi
affiliation not provided to SSRN, Government of the United States of America - Center for Drug Evaluation and Research, affiliation not provided to SSRN, Government of the United States of America - Center for Drug Evaluation and Research, Government of the United States of America - Center for Drug Evaluation and Research, affiliation not provided to SSRN, Washington University in St. Louis - Department of Molecular Microbiology, affiliation not provided to SSRN, Washington University in St. Louis - Department of Molecular Microbiology, affiliation not provided to SSRN, affiliation not provided to SSRN, Washington University in St. Louis - Department of Molecular Microbiology and Government of the United States of America - Center for Drug Evaluation and Research
Downloads 34 (1,263,436)

Abstract:

Loading...

SARS-CoV-2, spike protein, neurotropism, BSL-2 mouse model, VSV, Pseudotyped virus, ACE2 transgenic mice